Virostat Inc. Release: New Malaria Monoclonal Antibodies
Published: Oct 11, 2012
The majority of deaths are caused by P. falciparum. During the blood stage infection, P. falciparum secretes large quantities of a glycoprotein termed Histidine- Rich Protein II (HRP II). Detection of HRP II in serum or plasma correlates to active parasitemia.
ViroStat has released a new set of monoclonal antibodies to the HRP II protein of P. falciparum. These antibodies should be useful to researchers and those needing to develop rapid tests for this protein.
To download the data sheet for these NEW Antibodies and to obtain pricing, go to the ViroStat website at www.virostat-inc.com or call 207-856-6620
ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies, supplying researchers and manufacturers since 1985. Specialties include high affinity antibodies to Flu A, Flu B, RSV & Strep A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to HCV, HBV, CMV & EBV for use in anti-viral HTS assays
PO Box 8522
Portland, ME 04104 USA